Imaging the vulnerable carotid artery atherosclerotic plaque

Imaging the vulnerable carotid artery atherosclerotic plaque

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-001237-17-FI

Enrollment

50

Registered

2006-03-01

Start date

2004-09-10

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carotid atherosclerosis

Interventions

Product Name: F-18-FDG Pharmaceutical Form: Injection* Product Name: F-18-2-fluoro-2-deoxy-D-glucose Pharmaceutical Form: Injection*

Sponsors

Raitakari Olli

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: Tutkimuksessa pyritään selvittämään [18F]-FDG positroniemissiotomografia (PET)-kuvauksen käyttömahdollisuuksia haavoittuvan kaulavaltimoplakin tunnistamisessa aikuispotilailla, joilla on todettu merkittävästi kaulavaltimoa ahtauttava valtimokovettumatauti.;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026